With an $8.3 million Series A round in the warchest, Center City-based medical software company Proscia looks to triple in size and bring to market its artificial intelligence software for digital pathologists.
The round was led by Boston VC firm Flybridge Capital Partners, with participation from Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures and Philly’s RobinHood Ventures.
The company’s tech gives pathologists insights to improve the accuracy of diagnostics. Some 300 clinical and research facilities are now using the software. Under development are specific AI-enabled, disease-specific modules that help automate insights, the first of which is expected to hit the market by December.
Founded by David West Jr. and Coleman Stavish, in April the company relocated to Philly from Baltimore, where Stavish and West attended Johns Hopkins University. Currently a team of 20 full-timers mostly out of MakeOffices, the company hopes to triple in size.
West Jr., CEO of Proscia, said the funds will let the startup tackle key areas.
“[The funding] will allow us to expand the adoption of digital pathology, while creating intelligent systems that will unlock data from tissue to greatly enhance pathologists’ productivity, increase access to care, and improve the way cancer is researched, diagnosed, and ultimately treated,” West said in a press release.
“The market is moving quickly and we had a lot of appetite,” West Jr. said.-30-
This Week in Jobs: Careers as hot as the midsummer sun
On the Market: Why you should consider a dev job at this poverty reduction nonprofit
This Week in Jobs: Gaze straight into the eyes of these new jobs
Why Linode sent this manager to Mumbai for 7 months
This Week in Jobs: Hot dogs and hot jobs
California-based Flexport opening its 15th office in Center City
This Week in Jobs: Nothin’ to do but apply for jobs
This financial services firm offers global opportunity in the heart of Philly
Sign-up for daily news updates from Technical.ly Philadelphia